MedPath

Valproate Sodium

These highlights do not include all the information needed to use VALPROATE SODIUM INJECTION safely and effectively. See full prescribing information for VALPROATE SODIUM INJECTION. VALPROATE SODIUM injection, for intravenous injection onlyInitial U.S. Approval: 1996

Approved
Approval ID

3dfb6da1-f66a-4618-9f74-d2d6c16c0b58

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 1, 2022

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

VALPROATE SODIUM

PRODUCT DETAILS

NDC Product Code63323-494
Application NumberANDA076539
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMay 31, 2019
Generic NameVALPROATE SODIUM

INGREDIENTS (4)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.4 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
VALPROATE SODIUMActive
Quantity: 100 mg in 1 mL
Code: 5VOM6GYJ0D
Classification: ACTIM
© Copyright 2025. All Rights Reserved by MedPath
Valproate Sodium - FDA Approval | MedPath